Lv2
128 积分 2025-07-10 加入
Epcoritamab monotherapy or epcoritamab with lenalidomide as first-line therapy for patients with diffuse large B-cell lymphoma (EPCORE DLBCL-3): primary analysis of an open-label, multicentre, randomised, phase 2 trial
18天前
已完结
Final results of nilotinib versus nilotinib combined with pegylated interferon alfa-2a as first-line therapy in chronic phase chronic myeloid leukaemia in France (PETALs): an open-label, multicentre, randomised phase 3 trial
1个月前
已完结
Teclistamab plus Daratumumab in Relapsed or Refractory Multiple Myeloma
4个月前
已完结
Pharmacokinetic and tissue distribution study of pectolinarigenin in rats using UPLC-MS/MS
6个月前
已完结
Phased Variant–Supported Circulating Tumor DNA as a Prognostic Biomarker After First-Line Treatment in Large B-Cell Lymphoma: Findings From the DIRECT Study
6个月前
已关闭
2025 Update on MRD in Acute Myeloid Leukemia: A Consensus Document from the ELN-DAVID MRD Working Party
7个月前
已完结
FLT3-ITD measurable residual disease from the QuANTUM-First trial
7个月前
已完结
Long-term follow-up outcomes in congenital thrombotic thrombocytopenic purpura
8个月前
已关闭
A Prospective Study of Prophylactic Dexamethasone with Glofitamab in Relapsed/Refractory Large B-Cell Lymphoma
8个月前
已完结
A fusion strategy of network pharmacology and targeted metabolomics revealed anti-esophageal squamous cell carcinoma effect of Isodon rubescens and its heterogeneity
10个月前
已完结
Integrated Network Toxicology, Molecular Docking and Transcriptomics Reveal the Mechanistic Role of Phthalate Esters in Metabolic Disease Pathogenesis
7个月前
已采纳
Improved selectivity in eliciting evoked electromyography responses with high-resolution spinal cord stimulation
7个月前
已采纳
Identification of symptom trajectories in children with hematological malignancies along the chemotherapy cycle: A growth mixture model
10个月前
已采纳
Identification of symptom trajectories in children with hematological malignancies along the chemotherapy cycle: A growth mixture model
10个月前
已采纳
Biotransformation of metenolone acetate and epiandrosterone by fungi and evaluation of resulting metabolites for aromatase inhibition
1年前
已采纳
皖公网安备34019202002308
